RETRACTED ARTICLE: A meta-analysis and of clinical values of 11 blood biomarkers, such as AFP, DCP, and GP73 for diagnosis of hepatocellular carcinoma

B Pang, Y Leng, X Wang, Y Wang, L Jiang - Annals of medicine, 2023 - Taylor & Francis
Abstract We, the Editors and Publisher of the journal Annals of Medicine, have retracted the
following article: Bing-yaoPang, Yan Leng, Xiaoli Wang, Yi-qiang Wang & Li-hong Jiang …

Biomarkers in hepatocellular carcinoma: current status and future perspectives

Y Pan, H Chen, J Yu - Biomedicines, 2020 - mdpi.com
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and one of the
leading causes of cancer-related death worldwide. HCC is highly heterogeneous, both …

A novel fluorescent strategy for Golgi protein 73 determination based on aptamer/nitrogen-doped graphene quantum dots/molybdenum disulfide@ reduced graphene …

J Liang, R Yan, C Chen, X Yao, F Guo, R Wu… - … Acta Part A: Molecular …, 2023 - Elsevier
The effective detection of biomarkers associated with hepatocellular carcinoma (HCC) is of
great importance. Golgi protein 73 (GP73), a serum biomarker of HCC, has better diagnostic …

GP73-mediated secretion of AFP and GP73 promotes proliferation and metastasis of hepatocellular carcinoma cells

Y Liu, J Wang, R Yang, Y Cheng, Y Zhou, H Li, W Jiang… - Oncogenesis, 2021 - nature.com
Abstract Golgi protein 73 (GP73) and alpha fetoprotein (AFP) serve as biomarkers for the
diagnosis of hepatocellular carcinoma (HCC), and their serum levels correlate with patients' …

[HTML][HTML] Possible roles of Golgi protein-73 in liver diseases

MY Liu, L Huang, JF Wu, HB Zhang, WB Ai… - Annals of …, 2022 - Elsevier
Golgi protein 73 (also known as GP73 or GOLPH2) is a transmembrane glycoprotein
present in the Golgi apparatus. In diseased states, GP73 is expressed by hepatocytes rather …

[HTML][HTML] Integrative bioinformatics and experimental analysis revealed TEAD as novel prognostic target for hepatocellular carcinoma and its roles in ferroptosis …

X Ren, X Wang, Y Yan, X Chen, Y Cai, Q Liang… - Aging (Albany …, 2022 - ncbi.nlm.nih.gov
Objective: Transcriptional enhanced associate domain (TEAD) family consists of four
members TEAD1/2/3/4 that regulate cell growth, stem cell functions and organ development …

Hepatitis B virus-induced hepatocellular carcinoma: a persistent global problem

S Boora, V Sharma, S Kaushik, AV Bhupatiraju… - Brazilian Journal of …, 2023 - Springer
Hepatitis B virus (HBV) infections are highly prevalent globally, representing a serious public
health problem. The diverse modes of transmission and the burden of the chronic carrier …

The Golgi Apparatus as an Anticancer Therapeutic Target

M Martins, J Vieira, C Pereira-Leite, N Saraiva… - Biology, 2023 - mdpi.com
Simple Summary Even though scientists discovered the Golgi apparatus (GA) more than
125 years ago, there are only a few treatments that focus on this important part of the cell …

Potential lncRNA Biomarkers for HBV‐Related Hepatocellular Carcinoma Diagnosis Revealed by Analysis on Coexpression Network

S Nong, X Chen, Z Wang, G Xu, W Wei… - BioMed research …, 2021 - Wiley Online Library
Background. Increasing evidence demonstrated that long noncoding RNA (lncRNA) could
affect inflammatory tumor immune microenvironment by modulating gene expression and …

Fluorescence/electrochemical dual-mode strategy for Golgi protein 73 detection based on molybdenum disulfide/ferrocene/palladium nanoparticles and nitrogen …

G Li, R Yan, W Chen, R Wu, J Liang, J Chen, Z Zhou - Microchimica Acta, 2024 - Springer
Abstract Golgi protein 73 (GP73) is a new serum marker associated with early diagnosis and
postoperative assessment of hepatocellular carcinoma (HCC). Herein, an electrochemical …